Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: Evidence for differences between retroocular and dermal fibroblasts

T. J. Smith, R. S. Bahn, C. A. Gorman

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Fibroblasts derived from retroocular connective tissue and skin were propagated in culture in an effort to identify structural and functional differences in connective tissue which might explain the apparent region-specific involvement in Graves' disease. Striking morphological differences existed between cultured cells from the two anatomical sites. Inhibition of glycosaminoglycan (GAG) accumulation by T3 and dexamethasone in these cultures was compared. Confluent cultures were labeled with [3H] acetate, and total [3H]GAG was quantitated. Fibroblasts from the skin responded to T3 (100 nmol/L) and dexamethasone (100 nmol/L) with 27% and 55% inhibition of [3H]GAG accumulation, respectively (n = 12). In contrast, retroocular fibroblast responded with 12% and 8% inhibition (n = 6) to the two hormones. When cultures from abdominal skin and retroocular tissue were treated with n-butyrate (10 mM), a compound known to inhibit hyaluronate specifically, they responded similarly with 78% and 83% inhibition, respectively. A pulse-chase study was performed using fibroblasts from both sites, and no [3H]GAG degradation could be detected for the duration of the chase period (up to 72 h). These results suggest that retroocular fibroblasts, likely participants in the pathogenesis of Graves' ophthalmopathy, do not respond vigorously to T3 glucocorticoids in terms of inhibition of [3H]GAG synthesis as do their dermal counterparts.

Original languageEnglish (US)
Pages (from-to)1019-1023
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume69
Issue number5
StatePublished - 1989

Fingerprint

Fibroblasts
Glycosaminoglycans
Skin
Tissue
Connective Tissue
Dexamethasone
Graves Ophthalmopathy
Butyrates
Graves Disease
Glucocorticoids
Cultured Cells
Acetates
Cells
Hormones
Degradation

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts : Evidence for differences between retroocular and dermal fibroblasts. / Smith, T. J.; Bahn, R. S.; Gorman, C. A.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 69, No. 5, 1989, p. 1019-1023.

Research output: Contribution to journalArticle

@article{b47694142f3c4782b93f5a651324c25c,
title = "Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: Evidence for differences between retroocular and dermal fibroblasts",
abstract = "Fibroblasts derived from retroocular connective tissue and skin were propagated in culture in an effort to identify structural and functional differences in connective tissue which might explain the apparent region-specific involvement in Graves' disease. Striking morphological differences existed between cultured cells from the two anatomical sites. Inhibition of glycosaminoglycan (GAG) accumulation by T3 and dexamethasone in these cultures was compared. Confluent cultures were labeled with [3H] acetate, and total [3H]GAG was quantitated. Fibroblasts from the skin responded to T3 (100 nmol/L) and dexamethasone (100 nmol/L) with 27{\%} and 55{\%} inhibition of [3H]GAG accumulation, respectively (n = 12). In contrast, retroocular fibroblast responded with 12{\%} and 8{\%} inhibition (n = 6) to the two hormones. When cultures from abdominal skin and retroocular tissue were treated with n-butyrate (10 mM), a compound known to inhibit hyaluronate specifically, they responded similarly with 78{\%} and 83{\%} inhibition, respectively. A pulse-chase study was performed using fibroblasts from both sites, and no [3H]GAG degradation could be detected for the duration of the chase period (up to 72 h). These results suggest that retroocular fibroblasts, likely participants in the pathogenesis of Graves' ophthalmopathy, do not respond vigorously to T3 glucocorticoids in terms of inhibition of [3H]GAG synthesis as do their dermal counterparts.",
author = "Smith, {T. J.} and Bahn, {R. S.} and Gorman, {C. A.}",
year = "1989",
language = "English (US)",
volume = "69",
pages = "1019--1023",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts

T2 - Evidence for differences between retroocular and dermal fibroblasts

AU - Smith, T. J.

AU - Bahn, R. S.

AU - Gorman, C. A.

PY - 1989

Y1 - 1989

N2 - Fibroblasts derived from retroocular connective tissue and skin were propagated in culture in an effort to identify structural and functional differences in connective tissue which might explain the apparent region-specific involvement in Graves' disease. Striking morphological differences existed between cultured cells from the two anatomical sites. Inhibition of glycosaminoglycan (GAG) accumulation by T3 and dexamethasone in these cultures was compared. Confluent cultures were labeled with [3H] acetate, and total [3H]GAG was quantitated. Fibroblasts from the skin responded to T3 (100 nmol/L) and dexamethasone (100 nmol/L) with 27% and 55% inhibition of [3H]GAG accumulation, respectively (n = 12). In contrast, retroocular fibroblast responded with 12% and 8% inhibition (n = 6) to the two hormones. When cultures from abdominal skin and retroocular tissue were treated with n-butyrate (10 mM), a compound known to inhibit hyaluronate specifically, they responded similarly with 78% and 83% inhibition, respectively. A pulse-chase study was performed using fibroblasts from both sites, and no [3H]GAG degradation could be detected for the duration of the chase period (up to 72 h). These results suggest that retroocular fibroblasts, likely participants in the pathogenesis of Graves' ophthalmopathy, do not respond vigorously to T3 glucocorticoids in terms of inhibition of [3H]GAG synthesis as do their dermal counterparts.

AB - Fibroblasts derived from retroocular connective tissue and skin were propagated in culture in an effort to identify structural and functional differences in connective tissue which might explain the apparent region-specific involvement in Graves' disease. Striking morphological differences existed between cultured cells from the two anatomical sites. Inhibition of glycosaminoglycan (GAG) accumulation by T3 and dexamethasone in these cultures was compared. Confluent cultures were labeled with [3H] acetate, and total [3H]GAG was quantitated. Fibroblasts from the skin responded to T3 (100 nmol/L) and dexamethasone (100 nmol/L) with 27% and 55% inhibition of [3H]GAG accumulation, respectively (n = 12). In contrast, retroocular fibroblast responded with 12% and 8% inhibition (n = 6) to the two hormones. When cultures from abdominal skin and retroocular tissue were treated with n-butyrate (10 mM), a compound known to inhibit hyaluronate specifically, they responded similarly with 78% and 83% inhibition, respectively. A pulse-chase study was performed using fibroblasts from both sites, and no [3H]GAG degradation could be detected for the duration of the chase period (up to 72 h). These results suggest that retroocular fibroblasts, likely participants in the pathogenesis of Graves' ophthalmopathy, do not respond vigorously to T3 glucocorticoids in terms of inhibition of [3H]GAG synthesis as do their dermal counterparts.

UR - http://www.scopus.com/inward/record.url?scp=0024415558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024415558&partnerID=8YFLogxK

M3 - Article

C2 - 2793988

AN - SCOPUS:0024415558

VL - 69

SP - 1019

EP - 1023

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -